| Source: |
| Type: measurement |
| Bioavailability (usually in %) absorbed by the body. |
| 8056- | KAE, | Kaempferol: advances in biosynthesis, molecular mechanisms, and therapeutic applications |
| - | Review, | Var, | NA | - | Review, | Diabetic, | NA |
| 9001- | L-Theanine, | Kinetics of L-theanine uptake and metabolism in healthy participants are comparable after ingestion of L-theanine via capsules and green tea |
| - | Human, | Nor, | NA |
| 8174- | Lap, | Lapatinib: a dual inhibitor of human epidermal growth factor receptor tyrosine kinases |
| - | in-vitro, | Var, | NA |
| 8172- | Lap, | Administration of Lapatinib with Food Increases Its Plasma Concentration in Chinese Patients with Metastatic Breast Cancer: A Prospective Phase II Study |
| - | Trial, | BC, | NA |
| 8171- | Lap, | Effects of food on the relative bioavailability of lapatinib in cancer patients |
| - | Trial, | Var, | NA |
| 8163- | LapC, | Lapachol, a compound targeting pyrimidine metabolism, ameliorates experimental autoimmune arthritis |
| - | in-vivo, | Arthritis, | NA |
| 8166- | LapC, | Enhanced antitumor efficacy of lapachol-loaded nanoemulsion in breast cancer tumor model |
| - | vitro+vivo, | BC, | NA |
| 8215- | LCA, | Determination of licochalcone A in rat plasma by UPLC–MS/MS and its pharmacokinetics |
| - | in-vivo, | Nor, | NA |
| 8218- | LCA, | Advances in Pharmacological Activities and Drug Delivery Systems of Licochalcone A |
| - | Review, | Nor, | NA |
| 8219- | LCA, | Licochalcone A Ameliorates Cognitive Dysfunction in an Alzheimer's Disease Model by Inhibiting Endoplasmic Reticulum Stress-Mediated Apoptosis |
| - | in-vivo, | AD, | NA |
| 8240- | LE, | Licorice flavonoids nanoparticles prepared by liquid antisolvent re-crystallization exhibit higher oral bioavailability and antioxidant activity in rat |
| - | in-vivo, | Nor, | NA |
| 8271- | LE, | Pharmacokinetic profile of glycyrrhizin in healthy volunteers by a new high-performance liquid chromatographic method |
| - | Human, | Nor, | NA |
| 8278- | LE, | Glycyrrhiza glabra (Licorice): A Comprehensive Review on Its Phytochemistry, Biological Activities, Clinical Evidence and Toxicology |
| - | Review, | Var, | NA |
| 1794- | LEC, | Effects of abomasal infusion of soybean or sunflower lecithin on nutrient digestibility and milk production in lactating dairy cows |
| - | in-vivo, | Nor, | NA |
| 1795- | LEC, | Chit, | Self-assembled lecithin-chitosan nanoparticles improve the oral bioavailability and alter the pharmacokinetics of raloxifene |
| - | in-vivo, | Nor, | NA |
| 1796- | LEC, | A comprehensive review on pleiotropic effects and therapeutic potential of soy lecithin |
| - | Review, | Var, | NA |
| 8145- | LF, | Neuroprotective Effects of Lactoferrin in Alzheimer's and Parkinson's Diseases: A Narrative Review |
| - | Review, | AD, | NA | - | Review, | Park, | NA |
| 8136- | LF, | Oral fate and stabilization technologies of lactoferrin: a systematic review |
| - | Review, | Nor, | NA |
| 8135- | LF, | Lactoferrin-A Regulator of Iron Homeostasis and Its Implications in Cancer |
| - | Review, | Var, | NA | - | Review, | AD, | NA |
| 8137- | LF, | Lactoferrin delivery systems: approaches for its more effective use |
| - | Review, | IBD, | NA |
| 8193- | LGE, | Targets and pathways involved in the antitumor activity of citral and its stereo-isomers |
| - | Review, | Var, | NA |
| 8200- | LGE, | Chemical Properties and Therapeutic Potential of Citral, a Monoterpene Isolated from Lemongrass |
| - | Review, | Var, | NA |
| 8292- | lign, | Anticancer potential of flaxseed lignans, their metabolites and synthetic counterparts in relation with molecular targets: current challenges and future perspectives |
| - | Review, | Var, | NA |
| 8295- | lign, | Distribution, biosynthesis and therapeutic potential of lignans |
| - | Review, | Var, | NA |
| 8314- | lign, | Reduction in Ki-67 in Benign Breast Tissue of High Risk Women with the Lignan Secoisolariciresinol Diglycoside (SDG) |
| - | Trial, | BC, | NA |
| 8297- | lign, | Pharmacokinetics of enterolignans in healthy men and women consuming a single dose of secoisolariciresinol diglucoside |
| - | Trial, | Nor, | NA |
| 8329- | LIN, | Microglial-targeting induced by intranasal linalool during neurological protection postischemia |
| - | in-vivo, | Stroke, | NA | - | in-vivo, | AD, | NA |
| 8326- | LIN, | Linalool in cancer pharmacology: pharmacokinetic limitations and preclinical cytotoxic evidence for translational development |
| - | Review, | Var, | NA |
| 8323- | LIN, | doxoR, | Efficacy of Combination Therapy with Linalool and Doxorubicin Encapsulated by Liposomes as a Two-in-One Hybrid Carrier System for Epithelial Ovarian Carcinoma |
| - | vitro+vivo, | Ovarian, | NA |
| 8382- | LT, | Luteolin as a dietary flavonoid for brain health: modulating neuroinflammation and cognitive decline in neurodegenerative disorders |
| - | Review, | AD, | NA | - | Review, | Park, | NA |
| 8375- | LT, | Luteolin, a flavone ingredient: Anticancer mechanisms, combined medication strategy, pharmacokinetics, clinical trials, and pharmaceutical researches |
| - | Review, | Var, | NA |
| 8379- | LT, | Luteolin and neuroinflammation: a multi-target therapeutic strategy for central nervous system disorders |
| - | Review, | Var, | NA | - | Review, | AD, | NA | - | Review, | Stroke, | NA |
| 8377- | LT, | Luteolin: exploring its therapeutic potential and molecular mechanisms in pulmonary diseases |
| - | Review, | Asthma, | NA |
| 8384- | LT, | Current situation and research progress of luteolin in the treatment of gastrointestinal malignant tumors |
| - | Review, | GC, | NA |
| 8386- | LT, | Luteolin induces apoptosis in Philadelphia chromosome-positive acute lymphoblastic leukemia cell by regulating the PI3K/AKT signaling pathway |
| - | in-vitro, | ALL, | SUP-B15 |
| 8390- | LT, | Luteolin in Inflammatory Bowel Disease and Colorectal Cancer: A Disease Continuum Perspective |
| - | Review, | IBD, | NA | - | Review, | CRC, | NA |
| 8398- | LT, | Luteolin: Nature's promising warrior against Alzheimer's and Parkinson's disease |
| - | Review, | AD, | NA | - | Review, | Park, | NA |
| 2910- | LT, | FA, | Folic acid-modified ROS-responsive nanoparticles encapsulating luteolin for targeted breast cancer treatment |
| - | in-vitro, | BC, | 4T1 | - | in-vivo, | NA, | NA |
| 2912- | LT, | Luteolin: a flavonoid with a multifaceted anticancer potential |
| - | Review, | Var, | NA |
| 2914- | LT, | Therapeutic Potential of Luteolin on Cancer |
| - | Review, | Var, | NA |
| 2920- | LT, | Formulation, characterization, in vitro and in vivo evaluations of self-nanoemulsifying drug delivery system of luteolin |
| - | in-vitro, | Nor, | NA | - | in-vivo, | Nor, | NA |
| 2919- | LT, | Luteolin as a potential therapeutic candidate for lung cancer: Emerging preclinical evidence |
| - | Review, | Var, | NA |
| 2916- | LT, | Antioxidative and Anticancer Potential of Luteolin: A Comprehensive Approach Against Wide Range of Human Malignancies |
| - | Review, | Var, | NA | - | Review, | AD, | NA | - | Review, | Park, | NA |
| 4292- | LT, | Luteolin for neurodegenerative diseases: a review |
| - | Review, | AD, | NA | - | Review, | Park, | NA | - | Review, | MS, | NA | - | Review, | Stroke, | NA |
| 8357- | Lut, | Comparison of lutein bioavailability from vegetables and supplement |
| - | Study, | Nor, | NA |
| 8356- | Lut, | Amount of fat in the diet affects bioavailability of lutein esters but not of alpha-carotene, beta-carotene, and vitamin E in humans |
| - | Trial, | Nor, | NA |
| 8343- | Lut, | Association of Lutein with Cancer: A Systematic Review of the Lutein Effects on Cellular Processes Involved in Cancer Progression |
| - | Review, | Var, | NA |
| 3528- | Lyco, | The Importance of Antioxidant Activity for the Health-Promoting Effect of Lycopene |
| - | Review, | Nor, | NA | - | Review, | AD, | NA | - | Review, | Park, | NA |
| 3268- | Lyco, | Lycopene as a Natural Antioxidant Used to Prevent Human Health Disorders |
| - | Review, | AD, | NA |
| 3260- | Lyco, | Lycopene in human health |
| - | Review, | Nor, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:792 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid